...spital público ou privado, ambulatório, núcleo hemoterápico, hemocentro – deverá ter o seu Comitê Transfusional. Multidisciplinar Amplamente divulgado: o CT deverá divulgar, para toda a comunidade hospitalar, as suas funções, área de atuação, composição, rotina e como os profissionais poderão acessá-lo (fluxo de informações dentro de cada instituição). Informativo, educativo e atualizado: o ......
...ical care (TRICC) study: prospective observational cohort study in a large UK intensive care unit. Vox Sang., [S.l.], v. 84, p. 211-218, 2003. 22. CIRCULAR of information: for the use of human blood and blood components. Bethesda, MD: American Association of Blood Banks, 2002. 23. COMO, J. J. et al. Blood transfusion rates in the care of acute trauma. Transfusion, [S.l.], v. 44, p. 809-813, 20......
...morbidity in highrisk vascular patients in the intensive care unit. Crit Care Med. 1993;21:860-66. 66. O’shaughnessy DF, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004;126:11-28. 67. Perkins JG, et al. Massive transfusion and nonsurgical hemostatic agents. Crit Care Med. 2008;35:S325-S339. 68. Popovsky MA. Transfusion reactions. 2.......
...Y, M.; PARR, M. J. Therapeutic approaches in trauma-induced coagulopathy. Minerva Anesthesiol., [S.l.], v. 71, p. 281-289, 2005. STANDARDS for blood banks and transfusion Services. 21st ed. Bethesda, MD: American Association of Blood Banks, 2002. STANWORTH, S. J. The evidence-based use of FFP an cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. Hematology Am. Soc.......
...c leukemia, the greatest benef t is achieved from a matched sibling allogeneic transplantation in f rst complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: f nal results of the International ALL Trial (MRC UKALL XII/ ECOG E2993). Blood 2008;111:1827–33. 126.Weisdorf D, Forman S. Allogeneic hema......